{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:25:26Z","timestamp":1781951126086,"version":"3.54.5"},"reference-count":11,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.neurol.2008.03.007","type":"journal-article","created":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T08:53:12Z","timestamp":1211446392000},"page":"605-607","source":"Crossref","is-referenced-by-count":45,"title":["Posterior reversible encephalopathy syndrome during sunitinib therapy"],"prefix":"10.1016","volume":"164","author":[{"given":"R.","family":"Cumurciuc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Martinez-Almoyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"de Broucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2008.03.007_bib1","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archneur.63.10.1475","article-title":"Reversible posterior leucoencephalopathy syndrome after bevacizumab\/FOLFIRI regimen for metastatic colon cancer","volume":"63","author":"Allen","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2008.03.007_bib2","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2008.03.007_bib3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJMc052954","article-title":"Reversible posterior leukoencephalopathy syndrome and bevacizumab","volume":"354","author":"Glusker","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurol.2008.03.007_bib4","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1200\/JCO.2006.08.4608","article-title":"Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006","volume":"24","author":"Govindarajan","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neurol.2008.03.007_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leucoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2008.03.007_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/0961203307078682","article-title":"Posterior Reversible Encephalopathy syndrome: another manifestation of CNS SLE","volume":"16","author":"Ishimori","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.neurol.2008.03.007_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.HYP.0000187899.34379.b0","article-title":"Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia","volume":"46","author":"Lam","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.neurol.2008.03.007_bib8","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1200\/JCO.2007.12.8710","article-title":"Reversible posterior leucoencephalopathy syndrome induced by sunitinib","volume":"25","author":"Martin","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neurol.2008.03.007_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11523-007-0050-9","article-title":"Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient","volume":"2","author":"Medioni","year":"2007","journal-title":"Targ Oncol"},{"key":"10.1016\/j.neurol.2008.03.007_bib10","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1001\/jama.295.21.2516","article-title":"Sunitinib in patients with metastatic renal cell carcinoma","volume":"295","author":"Motzer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2008.03.007_bib11","first-page":"981","article-title":"Reversible posterior leukoencephalopathy syndrome and bevacizumab","volume":"354","author":"Ozcan","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378708002932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378708002932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T07:22:03Z","timestamp":1545981723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378708002932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":11,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0035378708002932"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2008.03.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}